10 Biggest Mid-Day Market Losers

By: via Benzinga
Aduro BioTech Inc (NASDAQ: ADRO) down 25.16% on missing primary endpoint with phase 2b eclipse trial. Virtusa Corporation ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.